Pak1 and Pak2 act as redundant regulators of skeletal myoblast differentiation in vitro and in vivo via the Ncad/Cdo/Cdc42 signaling pathway.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open Pak1/2 as N-cadherin effectors in mammalian myoblast differentiation.
Skeletal myogenesis is regulated by signal transduction, but the factors and mechanisms involved are not well understood. The group I Paks Pak1 and Pak2 are related protein kinases and direct effectors of Cdc42 and Rac1. Group I Paks are ubiquitously expressed and specifically required for myoblast fusion in Drosophila We report that both Pak1 and Pak2 are activated during mammalian myoblast differentiation. One pathway of activation is initiated by N-cadherin ligation and involves the cadherin coreceptor Cdo with its downstream effector, Cdc42. Individual genetic deletion of Pak1 and Pak2 in mice has no overt effect on skeletal muscle development or regeneration. However, combined muscle-specific deletion of Pak1 and Pak2 results in reduced muscle mass and a higher proportion of myofibers with a smaller cross-sectional area. This phenotype is exacerbated after repair to acute injury. Furthermore, primary myoblasts lacking Pak1 and Pak2 display delayed expression of myogenic differentiation markers and myotube formation. These results identify Pak1 and Pak2 as redundant regulators of myoblast differentiation in vitro and in vivo and as components of the promyogenic Ncad/Cdo/Cdc42 signaling pathway.
No takes yet. Share an insight, caveat, or question.
Joseph et al. (2016) studied Skeletal muscle development and regeneration. Combined muscle-specific deletion of Pak1 and Pak2 vs. Individual genetic deletion of Pak1 and Pak2 or wild-type was evaluated on Muscle mass and myofiber cross-sectional area.
Synapse has enriched 10 related papers. Consider them for comparative context: